Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines
Clinical trial NCT04889209 · COMPLETED
Trial details
- NCT number
- NCT04889209
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2023-06-16
- Enrollment
- 867
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.